Target intelligence / Profile preview

ATP synthase membrane subunit f, mitochondrial (ATP5MF)

Target
ATP5MF
Molecular classification
Enzyme, Transporter (proton channel subunit), Mitochondrial protein
01

Overview

ATP synthase membrane subunit f, mitochondrial (ATP5MF) is a minor component of the mitochondrial ATP synthase complex, specifically part of the Fo domain, which forms the proton channel in the mitochondrial inner membrane. This enzyme complex is responsible for synthesizing ATP from ADP and inorganic phosphate using the energy stored in a transmembrane proton gradient established during oxidative phosphorylation. The ATP5MF subunit is essential for the normal function of the Fo domain and therefore for cellular energy metabolism. Genetic defects or altered regulation of ATP5MF are implicated in mitochondrial diseases and potentially in cancer and neurodegeneration[1][2][3][4][5][6][7].

Other names
ATP synthase F(0) complex subunit f, mitochondrialATP synthase F chain, mitochondrialF1Fo-ATPase synthase f subunitATP synthase f chain, mitochondrialF1Fo-ATP synthase complex Fo membrane domain f subunitATP5J2ATP5JLATP synthase, H+ transporting, mitochondrial F0 complex, subunit fATP synthase, H+ transporting, mitochondrial Fo complex subunit F2F1F0-type ATPase subunit f
02

Mechanism of action

Inhibition of ATP synthase proton channel (general, by drugs like oligomycin, likely targeting Fo complex, not specifically subunit f) ; Modulation of mitochondrial energy production (general, for ATP synthase inhibitors)

03

Biological functions

ATP synthesis by oxidative phosphorylationProton translocation across mitochondrial membraneCellular energy metabolism
04

Disease associations

Mitochondrial diseaseCombined oxidative phosphorylation deficiencyNeurodegenerative disease (emerging evidence)[7]Cancer (energy metabolism regulation)[5]
05

Safety considerations

Global inhibition risks severe energy metabolism compromise (cytotoxicity, organ failure)Mitochondrial toxicity is a major concern with ATP synthase targeting agentsSpecific targeting of subunit f has not been associated with distinct side effects, as clinical experience is lacking
06

Interacting drugs

None directly listed in current sources; ATP synthase is affected by drugs like oligomycin, but specificity to subunit f (ATP5MF) is not established[1][2][3].
07

Biomarkers

Dysfunction or altered expression in mitochondrial disease diagnostics[2]Investigational in neurodegenerative and cancer metabolism disorders, but not established as routine biomarker[5][7]

Beyond the preview

Go deeper on ATP synthase membrane subunit f, mitochondrial (ATP5MF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP synthase membrane subunit f, mitochondrial (ATP5MF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call